It is a pharma private limited company based in Gurgaon, Haryana, India, established in 2020.
2020 | Gurgaon, Haryana, India | ActiveElixir Pharmaceuticals Private Limited, a active private limited company, was established on 29 July 2020 in Gurgaon, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85100HR2020PTC087947. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Prashant Kumar Agarwal (Director), Vishal Agarwal (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Adani Oyster Grande, Flat No D-102 Opp. Delhi Public School, Sector-102, Gurgaon, Haryana, 122001.
U85100HR2020PTC087947
087947
29 July 2020
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Elixir Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prashant Kumar Agarwal | Director | 29 Jul 2020 | Current |
| Vishal Agarwal | Director | 29 Jul 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Elixir Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 21.26% increase. The company also saw a substantial improvement in profitability, with a 119.46% increase in profit. The company's net worth Soared by an impressive increase of 16.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Elixir Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Elixir Pharmaceuticals has a workforce of 0 employees as of Mar 03, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Elixir Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixir Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Elixir Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Elixir Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Prashant Kumar Agarwal was appointed as a Director was appointed as a Director on 29 Jul 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
Progress on Vishal Agarwal was appointed as a Director was appointed as a Director on 29 Jul 2020 & has been associated with this company since 5 years 3 months . was documented.
Progress on Elixir Pharmaceuticals Private Limited was registered on 29 Jul 2020 with Roc Delhi & aged 5 years 3 months as per MCA records. was documented.
The CIN of Elixir Pharmaceuticals Private Limited is U85100HR2020PTC087947.
Elixir Pharmaceuticals Private Limited is headquartered at C/O Adani Oyster Grande, Flat No D-102 Opp. Delhi Public School, Sector-102, Gurgaon, Haryana, 122001.
Elixir Pharmaceuticals Private Limited was incorporated on 29 July 2020.
The current directors of Elixir Pharmaceuticals Private Limited are
The primary industry of Elixir Pharmaceuticals Private Limited is Trade.
Elixir Pharmaceuticals Private Limited is unlisted.
The authorized capital of Elixir Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX